CoChat

20 S-Hydroxyvitamin D3, Noncalcemic Product of CYP11A1 Action on Vitamin D3, Exhibits Potent Antifibrogenic Activity in Vivo

Open access
Slominski, Andrzej, Janjetovic, Zorica, Tuckey, Robert C., Nguyen, Minh N., Bhattacharya, Keka G., Wang, Jin, Li, Wei, Jiao, Yan, Gu, Weikuan, Brown, Monica, Postlethwaite, Arnold E. · 2013 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

CONTEXT: There is no effective treatment for systemic sclerosis and related fibrosing diseases. Recently the action of CYP11A1 on vitamin D(3) was shown to produce biologically active 20S-hydroxyvitamin D [20(OH)D(3)] and 20,23(OH)(2)D(3), 20,22(OH)(2)D(3), and 17,20,23(OH)(3)D(3). OBJECTIVES: Because 20(OH)D(3) is noncalcemic (nontoxic) in vivo at very high doses, we evaluated its antifibrogenic activities both in vitro and in vivo. Because it is further metabolized by CYP11A1, we also tested preclinical utilities of its hydroxyderivatives, especially 20,23(OH)(2)D(3). DESIGN: Human dermal fibroblasts from scleroderma and normal donors were used to test the efficiency of hydroxyvitamin D derivatives in inhibiting TGF-β1-induced collagen and hyaluronan synthesis and inhibiting cell proliferation. The in vivo activity of 20(OH)D(3) was tested using bleomycin-induced sclerosis in C57BL/6 mice. RESULTS: 20(OH)D(3) and 20,23(OH)(2)D(3) inhibited TGF-β1-induced collagen and hyaluronan synthesis similarly to 1,25(OH)(2)D(3) in cultured human fibroblasts. Also, 20(OH)D(3), 20,23(OH)(2)D(3), and 1,25(OH)(2)D(3) suppressed TGF-β1-induced expression of COL1A2, COL3A1, and hyaluronan synthase-2 mRNA, indicating that they regulate these matrix components at the transcriptional level. 20(OH)D(3), 20,23(OH)(2)D(3), 20,22(OH)(2)D(3), and 17,20,23(OH)(3)D(3) inhibited proliferation of dermal fibroblasts with comparable potency with 1,25(OH)(2)D(3), with 20(OH)D(2) being less active and 1α(OH)D(3) being almost inactive. 20,23(OH)(2)D(3) at 3 μg/kg had no effect on serum Ca(++) or fibroblast growth factor-23 levels and did not cause any noticeable signs of morbidity. 20(OH)D(3) markedly suppressed fibrogenesis in mice given sc bleomycin as demonstrated by total collagen content and hematoxylin and eosin staining of skin biopsies. CONCLUSIONS: 20(OH)D(3) is an excellent candidate for preclinical studies on scleroderma, with other CYP11A1-derived products of its metabolism deserving further testing for antibrogenic activity.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2012-3074

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 25 references

Cited by

Metadata

Authors
Slominski, A., Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Bhattacharya, K. G., Wang, J., Li, W., Jiao, Y., Gu, W., Brown, M., & Postlethwaite, A. E.
Affiliations
  • University of Tennessee Health Science Center (US)
  • The University of Western Australia (AU)
  • Campbell Clinic (US)
Corresponding author
  • Slominski, Andrzej
  • Postlethwaite, Arnold E.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-02
Volume
98
Issue
2
Pages
E298-E303
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1972743589
Cited by
89
References
25
Citations by year
2026: 1 · 2025: 2 · 2024: 8 · 2023: 2 · 2022: 7 · 2021: 13 · 2020: 9 · 2018: 5 · 2017: 2 · 2016: 10 · 2015: 12 · 2014: 13 · 2013: 5
FWCI
10.22
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (R01A052190)
  • Health Science Center, University of Tennessee
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052190, R21AR063242, R01AR056666)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
Keywords
CYP11A1, vitamin D3 metabolism, systemic sclerosis, TGF-β1, collagen synthesis, hyaluronan synthesis, dermal fibroblasts, bleomycin-induced lung fibrosis, 1,25-dihydroxyvitamin D3
MeSH terms
Animals, Calcifediol, Cells, Cultured, Collagen, Disease Models, Animal, Fibroblasts, Humans, Hyaluronic Acid, Mice, Inbred C57BL, Scleroderma, Systemic, Skin, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.